SM Empreendimentos-Purifarma deal to be reviewed by Brazil’s CADE
Brazil's antitrust authority will review SM Empreendimentos Farmacêuticos's proposed acquisition of competitor Purifarma in the pharmaceutical sector. Both companies have asked the Administrative Council for Economic Defense, or CADE, to approve...To view the full article, register now.
Already a subscriber? Click here to view full article